Stay updated on KarMMa Clinical Trial: bb2121 in RRMM

Sign up to get notified when there's something new on the KarMMa Clinical Trial: bb2121 in RRMM page.
Latest website image capture
Clouds background image

Latest updates to the KarMMa Clinical Trial: bb2121 in RRMM page

  1. Check
    yesterday
    Change Detected
    Summary
    Version bumped to v3.0.2; removed the Multiple myeloma topic link and the Back to Top element.
    Difference
    0.3%
    Check dated 2025-09-13T17:38:38.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1.
    Difference
    0.1%
    Check dated 2025-09-06T15:13:44.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The webpage has been updated to include new information about idecabtagene vicleucel, including additional studies and details about its use in treating multiple myeloma, while also removing some previously listed locations and terms.
    Difference
    7%
    Check dated 2025-08-30T11:50:52.000Z thumbnail image
  4. Check
    23 days ago
    No Change Detected
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.0%
    Check dated 2025-08-16T04:32:45.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.10 to version 2.16.11.
    Difference
    0.0%
    Check dated 2025-08-08T23:50:58.000Z thumbnail image
  7. Check
    44 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.
    Difference
    0.7%
    Check dated 2025-08-01T19:22:30.000Z thumbnail image

Stay in the know with updates to KarMMa Clinical Trial: bb2121 in RRMM

Enter your email address, and we'll notify you when there's something new on the KarMMa Clinical Trial: bb2121 in RRMM page.